DOCSLIB.ORG

The Pursuit of Safe Cannabis and Hemp For

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Pursuit of Safe Cannabis and Hemp For Table of Contents Welcome Letter....................................................page 4 Unity Sponsors....................................................page 8 ASA Board of Directors.....................................page 11 ASA Staff...............................................................page 12 Agenda...................................................................page 15 Speaker Biographies..........................................page 19 Save the Date! ASA 2021 Information..........page 28 6th: Absolute cleanliness is Godliness! Balanced food for body-mind-soul-spirit is our medicine! Full truth our God, half-truth our enemy, hard work our salvation, unity our goal, Free Speech our weapon, All-One our soul, self-discipline the key to fr eedom, All-One!!! unit y, unite l ove help unites o, S e! All-One wledg kno ab to ov y e! ke F or the we is ’r e All-One! epetition R As ools! f t each f or andering 6, w 000 e ’r we ye or ar s astr onomer mankind, unite s Abr Help aham last! & n’t Isr wo ael: “ disappointments , past the of out eep k , els jew en giv re a ” arless fe E xc the ep To tions Eternally rthwhile! wo ? ays Absolute alw is e lif , None!!! smile a S o, with when orld w y our the f ce ello Fa GOOD FOR YOU AND SPACESHIP EARTH. w man All-One! y ou One! measur e, Uniting t ak ee! fr e him at mankind his all FAMILY SOAPMAKERS SINCE 1858 MUCH LOVED FOR GOOD REASON best: True to the vision of Dr. E.H. Bronner and Cleanliness is Godliness! 18 uses in 1 mild with e-unite ov -l 157 years of soapmaking tradition: Work yet mighty soap. Eective, ecological, that ork w hard! Improve! Make the best better! versatile–vegan and cruelty-free. Certi- le ve to w r, Seek the purest, most eective organic ed Fair Trade ingredients, made with lift ho and fair trade ingredients, like hemp oil organic oils, no harsh synthetics. 100% him enemy 100% higher & for a soft, smooth lather that won’t dry biodegradable in a post-consumer Available in Eucalyptus, Rose, Tea Tree, Citrus Orange, Almond, Baby Unscented, Peppermint and Lavender your skin. Body, hair, face, mouth & teeth – recycled bottle. Enjoy only 2 cosmetics, , ov friend food, dishes, laundry, mopping, pets – Dr. enough sleep & Dr. Bronner’s Magic Soaps DR. BRONNER’S In all we do, let us be generous, erlook teach Bronner’s is the very best soap for hu- to clean body-mind-soul-spirit instantly fair & loving to Spaceship Earth IS CERTIFIED and all its inhabitants. For we’re the Then man, home and Earth. Dilute! Dilute! OK! uniting One! For we’re All-One or None! CONTAINS AT LEAST 70% FAIR TRADE INGREDIENTS FAIR FOR LIFE CERTIFIED BY IMO - - re st ! done! h 7t Get Get d! har ork w , time a at thing one Do ead! d ’s He ault? f without man the Find ahead! ears y 10 act & Think friend. my , smile & e ag our c ve Ha hate! -true half no e, -mat r ove -l -teacher ainer -tr -builder vider o -pr pilot ect perf a be to d har s ork w swallow Each : Welcome Letter Welcome to Unity 2020! Thank you for joining us from your home. I hope that you are safe and healthy. We learn a lot about what is important during times like these and as I write this I am overwhelmed with gratitude for the long lasting friendships I have made on my journey with Americans for Safe Access. A journey that started almost two decades ago. Through our work we have changed the social fabric of not just our society but the global perspective on medicine. As a point in case, last Monday, March 16th, ASA sent out a letter to call on governors and directors of state medical cannabis programs to take immediate action to ensure that patients continue to have access to medical cannabis and that the supply chain is not interrupted while Governors are creating emergency plans in their states to address the COVID-19 pandemic. We are happy to announce that as of today, 18 of the 33 states with medical cannabis laws have deemed medical cannabis business “essential” alongside pharmacies and hospitals with more to come. This is heart-warming not only because it is a sign that our decades of struggle are being realized but also because, ASA, the organization we built together, and all of you, were ready to jump into action during the COVID-19 pandemic to make sure medical cannabis patients were not forgotten. As we move into a new decade, it is incredible to see how much has changed just in the last 10 years. On January, 1, 2010 there were only 13 states with medical cannabis programs. Today, 33 states, the District of Columbia, Guam, the Commonwealth of the Northern Mariana Islands, the U.S. Virgin Islands, and Puerto Rico have adopted laws creating programs that allow at least some patients legal access to medical cannabis. Across the country, there are 3 million medical cannabis patients, and 91% percent of Americans now live in states with some form of access to medical cannabis. In the last decade alone, cannabis has become a more popularized form of medicine than ever before; a CBS News poll of doctors showed that 88% of doctors were in favor of recommending cannabis as a treatment to patients. Doctors aren’t the only ones taking note, legislators have found medical cannabis programs to be one of the most popular policy platforms; a random sampling of Americans polled by Quinnipiac in 2018 responded 94% in favor when asked if they supported legal access to medical cannabis with a doctor’s recommendation. Welcome Letter However, despite all these advancements, cannabis retains its Schedule I status under the Controlled Substances Act, meaning the federal government still considers it to be a dangerous, highly addictive substance with no medical value. This continues to cause numerous conflicts between the federal government and the states that have enacted these programs. With 2020 being an election year, it is more important than ever this year to focus on patient issues and to let Congressional members know that your vote for them depends on their stance on medical cannabis. While it often seems like national legalization is right around the corner, we know that legalization alone will not guarantee access to all the patients that could benefit from this medicine, nor will it advance important issues like medical professional education or insurance. It is important to remember that despite all of the advances in medical cannabis across the states, half or more of these populations are left out of the programs because of financial, legislative, and regulatory barriers. Countries around the world are making reforms to get their citizens safe and affordable access to medical cannabis- regulated by a federal office- putting into place minimum standards for labeling and packaging, standards for cultivation, and standards for testing for pesticides, heavy metals, contaminants, adulterants, and other potential threats to health. American patients should expect the same. For this reason, last year ASA unveiled its new legislation that explores how to end this conflict through the creation of a new federal agency, the Office of Medical Cannabis Control (OMCC). As it stands, nearly a dozen different federal agencies from the DEA to the USDA play a role in regulating cannabis. Our plan seeks to consolidate their authority in the OMCC and calls for the descheduling of cannabis (or, failing that, the rescheduling of cannabis to a new Schedule V(A) that would allow for cannabis to be used as a frontline medication. This action would end the conflict between states and the federal government on cannabis policy. This year our priority is to bring the idea of a national regulatory framework for medical cannabis into the national conversation. Welcome Letter I am honored to know that ASA has played a critical role in many of the incredible advancements in medical cannabis policy across the U.S. and globally throughout our 18 years. ASA’s role as a thought leader in the field of medical cannabis has led to the legal and regulatory framework that has shaped the medical cannabis industry we see today. Driven by a commitment to patient advocacy, ASA will continue focusing on federal legislative strategies to expand access across the nation; this also means setting standards and expectations for the industry serving patients. It has been my honor to serve as ASA’s President and Founder for the last 18 years. As our community has grown and our voice has strengthened, it brings me great pride to see that ASA’s programs and projects have become pillars to the medical cannabis movement. Thank you for joining us this year and as the fight for safe access continues, I look forward to you being a part of our success of greater patient access. Sincerely, Steph Sherer Founder and President Americans for Safe Access ad 3 DRIVE THE CANNABIS MOVEMENT Secure Fair Access and Social Justice wmpolicy.com Thanks to Our Unity Sponsors! Diamond Titanium Sapphire Gold Thanks to Our Unity Sponsors! Silver Bronze Media Partners Patient Sponsor YOUR MEDICINE aura SHOULDN’T MAKE REDUCES PATIENT YOU SICK. SIDE EFFECTS WITH ARTIFICIAL ad 2 INTELLIGENCE WHY SHOULD YOU JOIN THE https:/ / research.aureliusdata.com / aura RESEARCH PLATFORM? PRECISION MEDICINE Because we believe certain Our drug, and disease speci�ic pro�iles will identify contraindications, reveal side effects and highlight cannabinoid compounds have the negative impacts. Our AI and deep learning will create unique pro�iles and precision solutions. potential to replace up to 40% AGNOSTIC ANALYSIS of traditional pharmaceuticals.
Load more

Recommended publications
  • The Razor Wire
    Autumn 2003 Vol. 7 No. 2 The Razor Wire Winter 2004 Nonviolent Offender Relief Act November 5th, 2003 introduced in House Time: 6:45 AM Stratford High School he Federal Prison Bureau Nonviolent Offender Relief Act of 2003, HR 3575, was introduced in the House of Representatives on November 21. Relief in the form of early release eligibility would come to prisoners at least 45 years of age who have served half their sentence, "Get on the ground! Get with no history of violence, or violations of institutional disciplinary regulations. (You will find the on the ground!" an full bill text on page 6.) officer yells as students The bill has been referred to the House Judiciary Committee where members will argue its fall to the floor. merits, listen to varied testimony from pro and con voices, and undoubtedly modify its language. If HR 3575 becomes law as it’s now written, its effects would be significant. Had a parole bill been introduced before, or simultaneously, it would have made comment easier for anyone attempting it formally. Many November Coalition members don’t expect HR 3575 to stand alone, or for very long. Thus, at this time of congressional interest, we encourage support for any bill offering relief to the imprisoned, assistance to former prisoners, and sentencing relief for ‘future drug offenders.’ There are bills in Congress in each broad category. That said, our members should appreciate how relentless pressure over the years has pushed proposed bills for early release into Congressional hearing rooms in 2003-4. This progress is "Hands on your head, evidence of a new era of popular democracy.
    [Show full text]
  • Cannabis Plant and Cannabis Resin
    World Health Organization Expert Committee on Drug Dependence 41st ECDD, November 12th - 16th 2018 Critical -Review - Cannabis Plant and Cannabis Resin Dear Esteemed Members of the 41st Expert Committee, We are a coalition of Civil Society Organizations that advocate for regulatory, distributive and redistributive public policy reform for ​Cannabis. Due to the commitments of the 186 state parties of the 1961 Single Convention, ​Cannabis​ remains classified within many National policies as a drug having no accepted medical value. These policies have disproportionate health, safety and economic impacts on traditional ​Cannabis farming regions, which are global. According the United Nations Office on Drugs and Crime (UNODC), cannabis cultivation was reported by ​“145 countries (or 85 percent of countries reporting to UNODC) over the period 2010–2016, representing 94 percent of the world’s total population”​. (38)1 Cannabis cultivation was reported through direct indicators such as cultivation or eradication reporting; or indirect indicators including seizures and origin of seizures. North America accounted for roughly 39 percent of the global total of cannabis production. South America, Central America and the Caribbean accounted for nearly 23 percent, whereas Africa, Asia, Europe and Oceania account for roughly 38 percent of cannabis production. (39)2 We offer this paper to the ECDD for your consideration of the medical and cultural value of Cannabis ​and geographic indication systems as a mechanism to support national regulation for traditional cannabis producing regions. Sincerely, Michael Krawitz​, Speaking for the Coalition of the Following Organizations: 1 World Drug Report 2018, ​Analysis of Drug Markets: Opiates, cocaine, cannabis, synthetic drugs,​ (United Nations publication, Sales No.
    [Show full text]
  • The Handbook of Cannabis Therapeutics: from Bench to Bedside
    Handbook of Cannabis Therapeutics From Bench to Bedside 9780789030979 Handbook of Cannabis Therapeutics From Bench to Bedside Size: 212 x 152mm Spine size: 26 mm Color pages: Binding: Paperback THE HAWORTH PRESS® Haworth Series in Integrative Healing Ethan Russo Editor The Last Sorcerer: Echoes of the Rainforest by Ethan Russo Professionalism and Ethics in Complementary and Alternative Medicine by John Crellin and Fernando Ania Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential by Franjo Grotenhermen and Ethan Russo Modern Psychology and Ancient Wisdom: Psychological Healing Practices from the World’s Religious Traditions edited by Sharon G. Mijares Complementary and Alternative Medicine: Clinic Design by Robert A. Roush Herbal Voices: American Herbalism Through the Words of American Herbalists by Anne K. Dougherty The Healing Power of Chinese Herbs and Medicinal Recipes by Joseph P. Hou and Youyu Jin Alternative Therapies in the Treatment of Brain Injury and Neurobehavioral Disorders: A Practical Guide edited by Gregory J. Murrey Handbook of Cannabis Therapeutics: From Bench to Bedside edited by Ethan B. Russo and Franjo Grotenhermen Handbook of Cannabis Therapeutics From Bench to Bedside Ethan B. Russo, MD Franjo Grotenhermen, MD Editors Routledge Taylor &. Francis Croup NEW YORK AND LONDON First Published by The Haworth Press, Inc., 10 Alice Street, Binghamton, NY 13904-1580. Transferred to Digital Printing 2010 by Routledge 270 Madison Ave, New York NY 10016 2 Park Square, Milton Park, Abingdon, Oxon, OX14 4RN For more information on this book or to order, visit http://www.haworthpress.com/store/product.asp?sku=5741 or call 1-800-HAWORTH (800-429-6784) in the United States and Canada or (607) 722-5857 outside the United States and Canada or contact [email protected] © 2006 by The Haworth Press, Inc.
    [Show full text]
  • 1 the Following Analysis Addresses Some of the Legal Issues Raised By
    The following analysis addresses some of the legal issues raised by the proposed Utah Medical Marijuana Initiative, which may appear on the ballot in November 2018. The Marijuana Initiative Will Allow Some People to Grow Their Own Marijuana. Holders of medical cannabis cards who live more than 100 miles from a cannabis dispensary would be allowed to grow “up to six cannabis plants for personal medical use ….” (Section 26-60b-201(6)(d).) Nothing in the Initiative allows the State to license or monitor homegrown marijuana operations. The Marijuana Initiative Will Allow People Who Grow Their Own Marijuana to Evade Purchase and Use Limits. The Marijuana Initiative allows users to purchase up to 2 oz. of cannabis (or 10 grams of tetrahydrocannabinol or cannabidiol) from dispensaries every 14 days.1 (Section 26-60b-502(3)-(4).) But nothing in the Initiative prevents a person who is authorized to grow his own marijuana from consuming more than that from his own home- grown plants (which can be very large) or from also buying the maximum amount from a dispensary. The Marijuana Initiative Will Create Significant Challenges for Law Enforcement. Law enforcement will have no way to distinguish between personally-grown legal marijuana and illegal marijuana. Additionally, law enforcement will have no way to distinguish illegally purchased marijuana from legally purchased marijuana. To be sure, a person who has a medical cannabis card who is in possession of cannabis must have “a label that identifies that the cannabis or cannabis product was originally sold from a licensed cannabis dispensary ….” (Section 26-60b-204.) But we see no reason why a cardholder could not keep a label from marijuana bought legally and show it to law enforcement to justify possession of illegally purchased marijuana.
    [Show full text]
  • Planning Commission Hearing Staff Report Hearing Date: October 23, 2019
    Planning Commission Hearing Staff Report Hearing Date: October 23, 2019 ITEM 3* The Provo City Department of Development Services requests an ordinance amendment to Sections 14.06.020; 14.08.020; 14.24.020; 14.26.020; 14.27.020; 14.27A.020; 14.28.020; and 14.29.020, to add a definition for Cannabis Production Establishment, to allow it as a permitted use in the A1.10 Agricultural and the FI Freeway Industrial Zones, and to list that use as not permitted in all other Agricultural and Industrial Zones. City-wide application. Brandon Larsen (801) 852-6408 PLOTA20190365 Applicant: Development Services Relevant History: Medical cannabis has been a frequently addressed subject in recent Utah State legislative sessions, Staff Coordinator: Brandon Larsen including the 2019 First Special Session. Recent amendments to Section 4-41a-406 of the Utah Code, as Property Owner: City-wide well as an inquiry to Development Services regarding the processing of cannabis, have caused staff to consider where cannabis production establishments should be *Council Action Required: Yes permitted within the City. Summary of Key Issues: Amendments to Section 4-41a-406 of the Utah Code provide that cannabis production establishments are permitted in all industrial and all ALTERNATIVE ACTIONS agricultural zones, unless a municipality has 1. Continue to a future date to obtain designated by ordinance at least one industrial zone additional information or to further consider (and at least one agricultural zone) in which the information presented. The next available operation of a cannabis production establishment is a permitted use. meeting date is November 13, 2019, at Staff has received a request for information 6:00 P.M.
    [Show full text]
  • Cannabis: Primer for the Pharmacy Provider
    Annual Meeting September 14, 2019 Medical Cannabis: Primer for the Pharmacy Provider Brad Winter, PharmD, BCACP Sarah Yost, PharmD, BCPS Ambulatory Clinical Pharmacists Disclosure Instructions: Authors have no conflicts of interest to disclose. Presentation will include discussion of off-label medication use. INTERMOUNTAIN HEALTHCARE AND AUTHORS HAVE NOT RESEARCHED OR INDEPENDENTLY VALIDATED ANY ASSERTIONS OR CLAIMS AS TO THE USE OF CANNABIS AS DESCRIBED IN THIS PRESENTATION. AS SUCH, INTERMOUNTAIN HEALTHCARE AND AUTHORS OFFERS NO ASSURANCE AS TO THE CANNABIS INFORMATION DESCRIBED HEREIN, ANY SUCH RELIANCE AND LIABILITY IS SOLELY ON THE INDIVIDUAL REVIEWING AND RELYING UPON ANY USE OF CANNABIS. Learning Objectives At the conclusion of this activity, pharmacists should be able to successfully: 1. Differentiate between tetrahydrocannabinol (THC) and cannabidiol (CBD) 2. Review available cannabinoid formulations that are allowed in the state of Utah 3. Review available literature for cannabis use in various qualifying conditions 4. Describe key details of the Utah Medical Cannabis Act Learning Objectives At the conclusion of this activity, pharmacy technicians should be able to successfully: 1. Differentiate between tetrahydrocannabinol (THC) and cannabidiol (CBD) 2. Review available cannabinoid formulations that are allowed in the state of Utah 3. Describe key details of the Utah Medical Cannabis Act Definitions Cannabis ‐ generic term for drugs produced from plants of the genus Cannabis Cannabinoid ‐ group of compounds produced by cannabis
    [Show full text]
  • Roseman-University-2019-Abstract
    Wednesday, March 6, 2019 Table of Contents Welcome from President Renee Coffman…………………………………………….3 Welcome from the Research Symposium Chairs..………………………………..4 Keynote Speakers…………………………………………………………………………………5 Utah Abstracts…………………………..………………..……….………………………….....7 Nevada Abstracts………………………………………………………………………..……..86 Roseman University Research Symposium 2019 Program 2 Friends and Colleagues, Welcome to the Fifth Annual Roseman University of Health Sciences Research Symposium. We are pleased and grateful to continue the momentum that has been building since our first Symposium five years ago. This year, we received 136 abstracts to date across our three campuses in South Jordan, UT and Henderson & Summerlin, NV as well as from a growing contingent from our colleagues outside of Roseman. We look forward to featuring the discoveries and scholarly work of our faculty members, staff, post-doctoral researchers, residents, and students from all of Roseman’s health disciplines. Many of the presenting authors both inside and outside of Roseman carry affiliations with other great universities and entities worldwide. Our presenters are immensely talented and in demand, working across borders to create solutions, collaborating with other great minds, and bridging our communities. This year’s abstracts cover a wide range of topics in various areas including bench-top science, clinical research, and educational research. These works independently and collectively represent prodigious planning, methodical execution, and deeply insightful findings. With a wide breadth and depth of scientific subject matter, they are steps towards solutions, solutions that advance not only our work and our national and international reputation, but advance the human race. Some of these presentations address a number of diseases including PTSD, HIV/AIDS, diabetes, cancer, depression and fatty liver disease.
    [Show full text]
  • Highlife Nr 3 2018
    #1 CANNABIS LIFESTYLE MAGAZINE ® HighLifeJuni/Juli 2018 GRATIS GANJA YOGA IK BEN HE-LE-MAAL LOS Jean Pierre Voncken vecht voor zijn dochter CBD-OLIE VOOR KINDEREN COMMISSIE WIETPROEF Verslag van binnenuit # Opbrengst hennepkwekerijen anders berekend? 3 Silicium versterkt de Si Si Si Si Si buitenste laag van de Si Si Si Si bladeren en stam, verbetert de weerstand tegen ziektes en stress. Si Si Si Si Silicium creëert een sterkere en dikkere Si Si stam. Si Si Si NO Fe 3 Ca Silicium reguleert en verbetert de opname Mn K Ca K Mn van nutriënten. Fe NO 3 Ca Fe NO BEKIJK DE K 3 Mn PRODUCT ANIMATIE! ATAMI.COM SILIC BOOST Boost up the strength WWW.ATAMI.COM 8 % (&$#!'( "$ !(%%#!$ L_051 SALES ATAMI.COM fe_N @ ( if ighl H aanBurgemeesters zet In dit nummer het schrijnende verhaal van een kweekster die uit haar woning werd gezet nadat een politiemacht van achttien agenten vijf wietplanten in een kweektent vond. De vrouw kweekte de plantjes vanwege medicinale redenen, VOORWOORD maar de burgemeester van Emmen was onverbiddelijk. Ze VAN DE moest haar eigen koopwoning drie maanden uit. UITGEVER De Nederlandse overheid voert een Belachelijk natuurlijk. De vrouw ging in hoger afspreken dat niet langer bestuursrechtelijk liberaal beleid t.a.v. cannabis. Het beroep en trok aan het langste eind. Maar en strafrechtelijk wordt opgetreden tegen gebruik van cannabis wordt in de Nederlandse Opiumwet niet strafbaar de gemeente geeft niet op. Gefinancierd kleinschalige hennepteelt voor medicinale gesteld. Vele gemeenten gedogen door onze belastingcenten gaan ze in hoger redenen. Uiteraard moet de teler dan coffeeshops van waaruit hasj en wiet beroep.
    [Show full text]
  • Doctors to Study Effectiveness of CBD by Fred Gardner
    “Good and bad in every group.” O’Shaughnessy’s $5.95 The Journal of Cannabis in Clinical Practice Summer 2010 Doctors to Study Effectiveness of CBD By Fred Gardner Tod Mikuriya, MD, did not live to see “Placeholder” Questionnaire it, but his dream of investigating the Why is this plant different medical potential of compounds in the from all other plants? INTRODUCING PROJECT CBD cannabis plant other than THC is now within the grasp of his successors. Our collective is involved in a research project to assess the The Society of Cannabis Clinicians, effects of strains relatively rich in cannabidiol (more than 4% the group Mikuriya founded in 1999, has CBD). Collective members who medicate with CBD-rich can- drafted a “Strain Evaluation Survey” to nabis are encouraged to take part in this research by report- collect data from patients who medicate ing your observations on the back of this form with cannabis in which cannabidiol Is CBD-rich Cannabis right for you? (CBD) is predominant Research suggests that CBD could be effective in easing CBD-rich cannabis will be available the symptoms of rheumatoid arthritis, diabetes, nausea, and at California and Colorado dispensaries inflammatory bowel disorders, among other difficult-to-con- by late summer —and soon thereafter, trol conditions. CBD is non-psychoactive and may counter inevitably, in other states where patients certain effects of THC. Patients who want the anti-inflamma- can legally use cannabis as medicine. tory, anti-pain, anti-anxiety, or anti-spasm effects of cannabis Twelve strains rich in cannabidiol delivered —possibly— without disconcerting euphoria or se- (CBD) have been identified in the year dation might prefer CBD-rich Cannabis.
    [Show full text]
  • Download Agenda
    8/10/2020 @ 10AM PST Veterans Cannabis Group Conference Call Update CONFERENCE CALL AGENDA Speaking Members; o Aaron Augustis Founder - Veterans Cannabis Group US Army Veteran of Operation Iraqi Freedom www.veteranscannabisgroup.com o Michael Krawitz Sergeant, disabled-retired USAF Executive Director VMCA http://www.veteransformedicalcannabis.org/ o Cherissa Jackson, is a Combat Veteran Nurse starting to engage in taking care of the female Veteran voice and now for cannabis and is AMVETS Chief Medical Officer. o Veterans Cannabis Coalition Eric Goepel https://www.veteranscannacoalition.org/ o COVID-19 updates from Veterans on the call from around the country NOTES WHO – World Health Organization, international treaty agreements regarding cannabis Michael Krawitz has been attending meetings and representing Veterans Changing their position on medical cannabis Voting in December – over the counter use for medical cannabis without a prescription Veterans Cannabis Coalition – community reinvestment grants, equity programs, etc. The More Act - https://www.cannabisdispensarymag.com/article/cannabis-industry-awaits-us-house- vote-more-act/ The Community Reinvestment Grant Program: Provides services to the individuals most adversely impacted by the War on Drugs, including job training, re-entry services, legal aid, literacy programs, youth recreation, mentoring and substance use treatment The Cannabis Opportunity Grant Program: Provides funds for loans to assist small businesses in the marijuana industry that are owned and controlled by socially and economically disadvantaged individuals The Equitable Licensing Grant Program: Provides funds for programs that minimize barriers to marijuana licensing and employment for the individuals most adversely impacted by the War on Drugs Take Action: Drug Policy Alliance | NORML Decriminalizes marijuana at the federal level by removing the substance from the Controlled Substances Act (de-scheduling), applies this retroactively to prior and current convictions, and enables states to set their own policies.
    [Show full text]
  • Download Bulletin 100801
    RAO BULLETIN 1 August 2010 Note: Anyone receiving this who does not want it request click on the highlighted automatic “Change address / Leave mailing list” tab at the bottom of the message this is attached to or hit reply and place the word "Remove" in the subject line. THIS BULLETIN CONTAINS THE FOLLOWING ARTICLES == Vet Insurance ~ Life ---------- (Practices under Investigation) == Minnesota Veterans Business Program -- (Loan Availability) == VA Presumptive VN Vet Diseases [09] -- (Funding in place) == VA Funding 2011 ------------------------ (Approved by House) == DoD Benefit Cuts ----------------------------------- (First Step?) == DoD Benefit Cuts [01] ------------ (BDD Initial Observations) == VA Pension [03] ---------------------------------- (Income Rules) == VA Burial Benefit [09] -------------- (Hmong Bill Introduced) == Mobilized Reserve 27 JUL 2010 ---------- (17,458 Decreases) == Tricare Overseas Fraud/Abuse [02] - (PI Indictment Dropped) == Tricare Overseas Program [03] ------------ (Transition Letters) == VA Prosthetics [06] -------------------------- (New Technology) == Americans with Disabilities Act ------------- (Time to Update) == Arlington National Cemetery [13] ------- (Mislabeled Graves) == Military Stolen Valor [18] ------ (Act Ruled Unconstitutional) == Military Stolen Valor [19] -------------------- (John Rodriguez) == Military Stolen Valor [20] ------------ (Ex-Walter Reed CSM) == Florida Veterans Homes [03] ----------- (New Home Opening) == Merchant Marine WWII Compensation [05] --- (Doc Rqmts) == Tricare
    [Show full text]
  • Cannabis Americana As “Cannabis Sa- by Physiological Methods
    —4— O’Shaughnessy’s • Spring 2006 Rare booklet reveals— Parke, Davis Marketed Cannabis Extracts To Doctors With “Buy American” Pitch By O’Shaughnessy’s News Service “Repeated tests have con- Archivist Michael Krawitz has ob- Drug Company Promotion tained via ebay a promotional booklet vinced us that Cannabis Ameri- attesting to the widespread medical use cana properly grown and cured is of cannabis in the U.S. almost a century fully as active as the best Indian ago. drug, while on the other hand The handsomely designed and printed we have frequently found Indian 16-page booklet was published by Parke, Davis & Co. to market its “Cannabis Cannabis to be practically inert.” Americana” to doctors and pharmacists —just as drug companies nowadays do describe as state-of-the art. when they have a potential “blockbuster” “Several years ago we began a emerging from the pipeline. systematic investigation of American Just as drug companies do nowadays, grown Cannabis Sativa. Samples from Parke , Davis knocks the competition, a number of localalities (sic) were ob- which in this instance was cannabis im- tained and carefully investigated. From ported from India. And just as they do these samples fluid and solid extracts nowadays, they invoke science to peddle were prepared according to the Pharma- their wares, although the science is not copoeal method, and carefully tested entirely rigorous (to put it mildly). upon animals for physiological activity, Under a first-page headline defining and eventually they were standardized Cannabis Americana as “Cannabis Sa- by physiological methods. Repeated tiva Grown in America,” the marketing tests have convinced us that Cannabis department gets right to the point: Americana properly grown and cured now consider the two plants to be iden- “Much has been written relative to the is fully as active as the best Indian tical.
    [Show full text]